US4002602A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Ubiquitous immunopoietic polypeptide (UBIP) and methods
Assignee: Individual
•
Filing: 1975-08-22
•
Granted: 1977-01-11
•
Expires: 1995-08-22
Abstract
Abstract There is disclosed a new Ubiquitous Immunopoietic Polypeptide (UBIP) which has been isolated in fluffy white powder form from bovine thymus but which has been found to be present in living cellular tissue of all animals and plants tested including various guinea pig tissues, cells in tissue cultures and tissues from birds, fish, squid, plants, fungi and bacteria, the polypeptide being characterized by its ability to induce in vitro, in nanogram concentrations, the differentiation of both T cell and B cell immunocytes from precursors present in bone marrow or spleen and thus the polypeptide is useful in therapeutic areas involving thymic or immunity deficiencies and the like. The polypeptide also exhibits hypotensive properties. The polypeptide is isolated from living source materials by a combination of sizing techniques and ion-exchange chromatography and may be described by the following amino acid structural sequence: H 2 n-met-gln-ile-phe-val-lys-thr-leu-thr-gly-lys-thr-ile-thr-leu-glu-val-glu-pro-ser-asp-thr-ile-glu-asn-val-lys-ala-lys-ile-gln-asp-lys-glu-gly-ile-pro-pro-asp-gln-gln-arg-leu-ile-phe-ala-gly-lys-gln-leu-glu-asp-gly-arg-thr-leu-ser-asp-tyr-asn-ile-gln-lys-glu-ser-thr-leu-his-leu-val-leu-arg-leu-arg-cooh
Inventors
- 👤 Gideon Goldstein
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-24 16:56
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/435; C07K14/575; A; A61; A61K; A61K38/00; Y; Y10; Y10S; Y10S530/00; Y10S530/827; Y10S530/854
Claims Analysis
Total Claims: 13
Claim 1
Independent Claim
12 words
A polypeptide which has the following amino acid sequence: H 2 n-met-gln-ile-phe-val-lys-thr-leu-thr-gly-lys-thr-ile-thr-leu-glu-val-glu-pro-ser-asp-thr-ile-glu-asn-val-lys-ala-lys-ile-gln-asp-lys-glu-gly-ile-pro-pro-asp-gln-gln-arg-leu-ile-phe-ala-gly-lys-gln-leu-glu-asp-gly-arg-thr-leu-ser-asp-tyr-asn-ile-gln-lys-glu-ser-thr-leu-his-leu-val-leu-arg-leu-arg-cooh.
Claim 2
Dependent Claim
12 words
A polypeptide which has the following amino acid sequence: H 2 n-met-gln-ile-phe-val-lys-thr-leu-thr-gly-lys-thr-ile-thr-leu-glu-val-glu-pro-ser-asp-thr-ile-glu-asn-val-lys-ala-lys-ile-gln-asp-lys-glu-gly-ile-pro-pro-asp-gln-gln-arg-leu-ile-phe-ala-gly-lys-gln-leu-glu-asp-gly-arg-thr-leu-ser-asp-tyr-asn-ile-gln-lys-glu-ser-thr-leu-his-leu-val-leu-arg-leu-arg-cooh.
Claim 3
Dependent Claim
126 words
a method for isolation of the polypeptide of claim 1 from bovine thymus which comprises homogenizing bovine thymus in buffered saline solution, heating at a temperature of about 60°-90° C., removing nonhomogenized and insoluble materials, subjecting to filtration on membranes to remove materials having molecular weights above about 100,000 dalton, subjecting the resulting solution to dialysis to remove materials having molecular weights below about 2,000 to recover a solution containing materials having molecular weights of about 2,000 to 100,000, fractionating by molecular exclusion chromatography to recover a solution containing materials having molecular weights of about 4,000 to 12,000, fractionating by adsorption chromatography at a pH of about 6.8, then further fractionating by ion exchange chromatography and lyophilizing to recover the highly purified polypeptide as a powder.
Claim 4
Dependent Claim
24 words
A method according to claim 2 wherein the starting bovine thymus is homogenized in about 25% wet weight per volume of 0.1M ammonium bicarbonate.
Claim 5
Dependent Claim
21 words
A method according to claim 3 wherein heating is carried out at a temperature of about 70° C. for 30 minutes.
Claim 6
Dependent Claim
24 words
A method according to claim 4 wherein the homogenized mixture is centrifuged after heating at 5,000 g for 30 minutes to remove non-homogenized materials.
Claim 7
Dependent Claim
51 words
A method according to claim 5 wherein the supernatant recovered from the centrifugation step is filtered to remove insolubles and subjected to filtration over a membrane which separates materials having molecular weights above about 100,000 by permitting materials having molecular weights of less than about 100,000 to pass through the membrane.
Claim 8
Dependent Claim
42 words
A method according to claim 6 wherein further dialysis is conducted by contact with membrane which permits materials of molecular weights of less than about 2,000 to pass through the membrane while retaining the materials which have molecular weights above about 2,000.
Claim 9
Dependent Claim
68 words
A method according to claim 7 wherein the retentate from the second dialysis step is fractionated by molecular exclusion chromatography by passage of a solution through a column containing a cross-linked dextran molecular sieve which totally excludes materials having molecular weights above about 30,000 and totally includes materials having molecular weights of below about 1,500 and recovering materials having molecular weights of about 4,000-12,000 from the chromatography step.
Claim 10
Dependent Claim
82 words
A method according to claim 8 wherein the materials having molecular weights of about 4,000-12,000 are further fractionated by adsorption chromatography by passage through a column containing hydroxyl apatite in 0.005M phosphate buffer solution at a pH of about 6.8 wherein the materials are dissolved in the same phosphate buffer solution, and separation is obtained by differential sticking on the hydroxyl apatite, the active fractions obtained by raising the concentration of the buffer to 0.05M and the recovered fractions lyophilized and desalted.
Claim 11
Dependent Claim
90 words
A method according to claim 9 wherein the recovered materials are further fractionated by ion exchange chromatography in the presence of a cation exchanger at a concentration of about 0.01 to 1.0M and at a pH of about 4.0-6.0 or an anion exchanger at a concentration of about 0.01M and a pH of about 7.5 to 11.0, wherein the ion exchanger comprises a backbone with polymer groups thereon wherein the product sticks to the beads and is later removed by raising the molarity of the solution by linear concentration gradients.
Claim 12
Dependent Claim
24 words
A method according to claim 10 wherein the fractions recovered from the ion exchange chromatography are lyophilized and desalted to recover the final product.
Claim 13
Dependent Claim
77 words
A method for isolation of the polypeptide of claim 1 from celery comprising extracting the juices from the celery, contacting the juices with a membrane to exclude materials having molecular weights above about 100,000 and below about 2,000, subjecting the resulting materials to fractionation by molecular exclusion chromatography to obtain materials having molecular weights of about 4,000 to about 12,000, subjecting the resulting materials to ion-exchange chromatography followed by lyophilizing and desalting to obtain the polypeptide product.
References Cited (Backward Citations)
US3951939A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1980-01-11 | 1980-07-12 | 1981-01-11 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1984-01-11 | 1984-07-12 | 1985-01-11 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1988-01-11 | 1988-07-12 | 1989-01-11 | $7700.00 | Window Closed / Lapsed |